Synageva BioPharma to Present at the Leerink Swann 2012 Global Healthcare Conference

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that it will be presenting at the upcoming Leerink Swann 2012 Global Healthcare Conference. Sanj K. Patel, President and Chief Executive Officer of Synageva, is scheduled to present on Thursday, February 16, 2012, at 8:30 AM Eastern Standard Time. The presentation will be webcast live and may be acce

Feed Date: 
February 14, 2012